06/01/2026
As we continue our integration into BioMarin, we will be retiring the Amicus Therapeutics Facebook presence on June 12.
We are deeply grateful to this community – your support, engagement and shared commitment to people living with rare conditions have shaped who we are and the impact we’ve made together.
As we move forward, we invite you to continue the journey with us by following BioMarin Pharmaceutical Inc., where our mission carries on with even greater reach and possibility.
Thank you for being such an important part of the Amicus story.